Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Clinical trial NCT06563323 · RECRUITING

Trial details

NCT number: NCT06563323
Sponsor: Oregon Health and Science University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pyoderma Gangrenosum Skin Diseases Wound Heal Pyoderma Skin Ulcer

Start date: 2025-02-01
Primary completion: 2027-08-13
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.